While NRAS and KRAS genes share conserved sequences, their protein products appear to regulate distinct oncogenic signaling events and to differently depend upon the downstream MEK pathway in NSCLC cells [151,152]. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.